Plain-English translation of NCT07686406 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large research study that collects blood, stool, and tissue samples from people with inflammatory bowel disease (including Crohn's disease and ulcerative colitis), their family members, and healthy volunteers. Researchers will use these samples to discover and test new biological markers—measurable signs in your body—that could help doctors better understand disease activity, monitor how well treatments are working, and predict which patients are at higher risk for worsening disease.
Currently, doctors struggle to objectively measure inflammation in inflammatory bowel disease and predict how individual patients will respond to treatment. This study aims to find new biological markers that could make disease monitoring more precise and help doctors personalize treatment plans for each patient.
You likely qualify if…
You likely don't qualify if…
You will visit a research center where doctors will collect samples of your blood and stool, and possibly intestinal tissue if you are having a routine endoscopy. You will also share your medical records, information about your symptoms and treatments, and results from imaging or lab tests your doctors have already done. The study will follow you over time to see how your disease progresses and how you respond to your regular medical care—researchers will not prescribe any new medications, but instead will observe and collect information during your routine clinic visits.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
China